Rapilif-M 50 Tablet ER
Marketer
Ipca Laboratories Ltd
Salt Composition
Mirabegron (50mg) + Silodosin (8mg)
Overview Rapilif-M 50 Tablet ER
Rapilif-M 50 ER tablets are a combined medication employed to manage benign prostatic hyperplasia (BPH). This treatment alleviates symptoms such as urinary hesitancy, but doesn't reduce prostate volume. Always adhere to your physician's prescribed dosage and regimen. Consumption can be with or without food, maintaining consistent daily timing. Swallow the tablet whole; avoid crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms, necessitating completion of the prescribed course for optimal results. Potential side effects include dizziness, diarrhea, retrograde ejaculation, orthostatic hypotension, headache, nasal congestion, and nasopharyngitis. Persistent or bothersome side effects warrant immediate medical attention. Simple lifestyle adjustments can aid symptom management. Urinate promptly upon feeling the urge, avoiding straining. Limit evening and pre-sleep consumption of caffeinated or alcoholic beverages. Prior to treatment, disclose all current medications and pre-existing conditions. Inform your ophthalmologist about Rapilif-M 50 ER use before cataract or glaucoma surgery. Individuals with hepatic or renal impairment require careful monitoring and regular checkups under their doctor's guidance.
Uses of Rapilif-M 50 Tablet ER
Noncancerous prostate gland enlargement
Major Benefits of Rapilif-M 50 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Rapilif-M 50 Tablet ER whole; avoid crushing, chewing, or breaking it. While you can take it with or without food, consistency is key—take it at the same time each day.
Common Side effects of Rapilif-M 50 Tablet ER:
- Retrograde ejaculation
- Dizziness
- Diarrhea
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Headache
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Nasal congestion (stuffy nose)
How to use Rapilif-M 50 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Rapilif-M 50 Tablet ER whole; avoid chewing, crushing, or fracturing it. This extended-release tablet can be consumed with or without food, though consistent timing is recommended.
How Rapilif-M 50 Tablet ER works:
Rapilif-M 50 Extended-Release tablets contain mirabegron and silodosin. Mirabegron eases bladder muscle contractions, reducing urinary urgency, frequency, and incontinence. Silodosin similarly relaxes muscles in both the bladder and prostate gland.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Rapilif-M 50 Tablet ER lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Data on Rapilif-M 50 Tablet ER use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Rapilif-M 50 Tablet ER while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Rapilif-M 50 Tablet ER's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding Rapilif-M 50 Tablet ER use in individuals with impaired renal function is scarce. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Rapilif-M 50 Tablet ER use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Rapilif-M 50 Tablet ER :
Should you forget a Rapilif-M 50 Tablet ER dose, administer it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rapilif-M 50 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Urology |


